Project ECHO: Ambulatory Alcohol Withdrawal Management and Treatment | Ambulatory WM for Alcohol (Medication Regiments)
Alcohol is the most widely misused substance in our communities, with harmful impacts on health outcomes across the lifespan. Nationally, excessive alcohol use contributes to more than 140,000 deaths each year, and in Maine, an average of 714 annual deaths are attributable to excessive alcohol use. This 6-month Project ECHO will highlight treatment and interventions for alcohol use disorders with a focus on ambulatory alcohol withdrawal management and treatment.
- Expand knowledge of management of ambulatory alcohol withdrawal management (WM)
- Build knowledge of effective treatment for alcohol use disorder (AUD)
- Bolster competencies to respond to alcohol use disorders
When: The first Friday of the month, beginning in January through June 2024, from 12:00 pm to 1:00 pm
Intended Audience: Primary care and specialty care SUD prescribers, individually or with their team members from practices located in Maine, who seek support to develop, implement, improve, and sustain OUD/SUD treatment for adults with AUD.
- Rachel Solotaroff, MD, MCR, FACP, Executive Clinical Director, Substance Use Disorders, Penobscot Community Health Care (facilitator)
- Mark Delon Lim, MD, Addiction Medicine, Physician, Maine Behavioral Healthcare
- David Lawrence, MD, FASAM, Assistant Clinical Professor at the UCLA David Geffen School of Medicine
- Eric Haram, LADC, Consultant
Engagement/motivational interviewing for decreasing EtOH use: David Lawrence, MD, (1/5/24) Risk stratification for alcohol WM: Mark Delon Lim, MD, (2/2/24)
- Ambulatory WM for alcohol (medication regiments): Rachel Solotaroff, MD, (3/1/24)
- Complex withdrawal management with multiple substances, including alcohol: David Lawrence, MD, (4/5/24)
- Psychosocial treatment: Eric Haram, LADC, (5/3/24)
- Medications for AUD: Mark Delon Lim, MD (6/7/24)
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Note: CME credits cannot be awarded for less than 1 hour.
This activity qualifies for 1 credit of the 3 CME credit requirement for opioid medication education found in P.L. 2015, Chapter 488, Maine’s legislation to address the opioid drug crisis.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit™.
Contact hours will be awarded at the end of the ECHO based upon 1 hour for each session attended:
- 1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals
- 1 Category I contact hour for psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Maine Psychologists.
- 1 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
- 1 contact hour pending for alcohol and drug counselors from the Maine board of alcohol and drug counselors.
The ME SUD Learning Community ECHO is funded by the Maine Department of Health and Human Services and coordinated by the Co-Occurring Collaborative Serving Maine
Rachel Solotaroff is the Executive Clinical Director of Substance Use Disorder Services at Penobscot
Community Health Care, where she provides patient care, oversees substance use disorders care
delivery in the outpatient setting, and providing medical direction for withdrawal management at New
Horizons. Prior to moving to Maine, Rachel served as Chief Medical Officer and then CEO at Central City
Concern in Portland, Oregon. Rachel’s interest lies in using a population health framework to address
the complex intersection of homelessness and substance use disorders, often accompanied by trauma,
social isolation, and mental illness. Rachel is a general internist with additional board certification in
Addiction Medicine, and holds a Masters in Clinical Research.